Colombier III Files S-1 for $260M SPAC IPO, Cites Dilution Risks

TL;DR

**Avoid this SPAC; the massive founder share dilution and inherent conflicts of interest make it a high-risk bet for public investors.**

AI Summary

Colombier Acquisition Corp. III (CLBR-UN) filed an S-1 to raise $260,000,000 through an initial public offering of 26,000,000 units at $10.00 per unit. Each unit consists of one Class A ordinary share and one-eighth of one warrant, with each whole warrant exercisable at $11.50 per share. The SPAC is a blank check company seeking a business combination within 24 months, extendable to 27 months under specific conditions. The sponsor, Colombier Sponsor III LLC, purchased 150,000 private placement units for $1,500,000 and holds 9,966,667 founder shares for a nominal $25,000, representing approximately 25% of outstanding shares post-IPO. This significant founder share ownership, acquired at $0.003 per share, poses a substantial dilution risk to public shareholders and creates potential conflicts of interest for management. Roth Capital Partners, LLC will receive 260,000 founder shares as upfront underwriting compensation, replacing a cash discount. The company will repay up to $300,000 in sponsor loans and reimburse an affiliate $10,000 monthly for administrative services.

Why It Matters

This S-1 filing signals another SPAC entering a crowded market, aiming to raise $260 million. For investors, the significant dilution from founder shares, acquired at a nominal $0.003 per share, means an immediate and substantial reduction in the implied value of their public shares, even if a business combination is successful. The potential for conflicts of interest among management, who could profit substantially even if the target business declines, adds another layer of risk. This filing highlights the ongoing challenges and structural issues within the SPAC model, where sponsor incentives may not fully align with public shareholder interests, intensifying competition for viable private companies.

Risk Assessment

Risk Level: high — The risk level is high due to the 'nominal purchase price paid by our initial shareholders for the founder shares' ($0.003 per share), which 'may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.' Additionally, the sponsor's 25% ownership of ordinary shares post-IPO, combined with potential conflicts of interest where officers and directors 'could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value,' presents a significant risk to public shareholders.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the substantial dilution and potential conflicts of interest outlined in this S-1. Given the high risk and misaligned incentives, a prudent investor might consider avoiding this offering or waiting for a definitive business combination target to assess its true value and management's commitment to public shareholder returns.

Key Numbers

• $260,000,000 — Gross proceeds from IPO (Targeted capital raise for the SPAC)
• 26,000,000 — Units offered (Number of units available at $10.00 each)
• $10.00 — Price per unit (Offering price for each unit in the IPO)
• $11.50 — Warrant exercise price (Price to purchase one Class A ordinary share per whole warrant)
• 24 months — Completion window for business combination (Initial timeframe to complete an acquisition, extendable to 27 months)
• 150,000 — Private placement units (Units purchased by the sponsor for $1,500,000)
• 9,966,667 — Founder shares (Class B ordinary shares owned by the sponsor for $25,000)
• $0.003 — Nominal price per founder share (Price paid by the sponsor for Class B ordinary shares, indicating significant dilution risk)
• 25% — Sponsor ownership (Percentage of ordinary shares owned by the sponsor post-IPO, on an as-converted basis)
• $300,000 — Sponsor loan repayment (Maximum amount to be repaid to the sponsor for offering-related expenses)

Key Players & Entities

• Colombier Acquisition Corp. III (company) — Registrant and blank check company
• Colombier Sponsor III LLC (company) — Sponsor of the SPAC
• Omeed Malik (person) — Chief Executive Officer of Colombier Acquisition Corp. III
• Roth Capital Partners, LLC (company) — Underwriter and future member of the sponsor
• SEC (regulator) — Securities and Exchange Commission
• NYSE (regulator) — New York Stock Exchange, intended listing venue
• Douglas S. Ellenoff, Esq. (person) — Counsel for the Registrant
• Stuart Neuhauser, Esq. (person) — Counsel for the Registrant
• OJJA II, LLC (company) — Affiliate of the sponsor providing administrative services
• $260,000,000 (dollar_amount) — Total proceeds from the IPO

FAQ

Risk Factors

• Dilution from Sponsor Shares [high — financial]: The sponsor, Colombier Sponsor III LLC, holds 9,966,667 founder shares acquired at a nominal price of $0.003 per share. This represents approximately 25% of the outstanding shares post-IPO, leading to significant potential dilution for public shareholders and raising concerns about alignment of interests.
• Redemption Risk [high — financial]: As a SPAC, Colombier Acquisition Corp. III faces the risk that a substantial portion of its public shareholders may redeem their shares if they do not approve of the proposed business combination. This could deplete the trust account, potentially making it difficult to complete a transaction or leaving insufficient capital for the target company.
• Failure to Complete Business Combination [high — operational]: The SPAC has a limited timeframe of 24 months (extendable to 27 months) to identify and complete a business combination. Failure to do so will result in liquidation, returning only the pro-rata portion of the trust account to public shareholders, with no return on their investment in units and warrants.
• Sponsor Loan Repayment [medium — financial]: The company is obligated to repay up to $300,000 in sponsor loans, which were likely used to fund initial operating expenses. While this is a defined amount, it represents a use of IPO proceeds that could otherwise be available for the business combination.
• Underwriting Compensation Structure [medium — financial]: Roth Capital Partners, LLC will receive 260,000 founder shares as upfront underwriting compensation, rather than a cash discount. This structure could incentivize the underwriters to push for a deal completion, even if it's not optimal for all shareholders.
• Dependence on Target Company Performance [high — operational]: Post-business combination, the success of Colombier Acquisition Corp. III will be heavily dependent on the performance of the acquired company. Any operational or financial missteps by the target could lead to significant value destruction for shareholders.

Industry Context

Colombier Acquisition Corp. III operates within the Special Purpose Acquisition Company (SPAC) industry. This sector has seen significant growth and subsequent volatility, with increased regulatory scrutiny. SPACs are increasingly competing with traditional IPOs and direct listings for attractive target companies, requiring speed and strategic deal-making.

Regulatory Implications

As a SPAC, Colombier Acquisition Corp. III is subject to SEC regulations governing initial public offerings and de-SPAC transactions. Potential changes in accounting rules and increased enforcement actions related to SPAC disclosures and projections pose ongoing compliance risks.

What Investors Should Do

1. Scrutinize the proposed business combination target carefully.
2. Assess the potential for dilution from founder shares and warrants.
3. Monitor the SPAC's progress towards a business combination within the 24-month timeframe.
4. Understand the redemption rights associated with public shares.

Glossary

Unit

A security consisting of one Class A ordinary share and one-eighth of one warrant, sold together in the IPO. (Represents the basic investment vehicle offered to the public in the IPO.)

Warrant

A security that gives the holder the right, but not the obligation, to purchase a share of Class A ordinary stock at a specified price ($11.50) within a certain timeframe. (Provides potential upside for investors but also adds to future dilution if exercised.)

Founder Shares

Class B ordinary shares typically held by the SPAC sponsor, often with different voting rights and conversion terms compared to Class A shares. (The significant ownership of founder shares by the sponsor at a low cost is a key factor in potential dilution and conflicts of interest.)

SPAC

Special Purpose Acquisition Company. A shell company that raises capital through an IPO to acquire an existing private company. (Defines the nature of Colombier Acquisition Corp. III and its primary objective.)

Trust Account

An account where the proceeds from the IPO are held in trust, typically invested in U.S. Treasury securities, until a business combination is completed or the SPAC liquidates. (Contains the capital available for the business combination and for potential redemptions by shareholders.)

Business Combination

The acquisition or merger of the SPAC with a target private company. (The core objective of the SPAC; failure to complete one within the specified timeframe leads to liquidation.)

Year-Over-Year Comparison

This is an initial S-1 filing for Colombier Acquisition Corp. III, therefore, there is no prior year filing to compare financial metrics or risk factors against. The filing outlines the proposed structure, risks, and objectives of the SPAC as it seeks a target for a business combination.

Key Financial Figures

• $260,000,000 — BER 17, 2025 PRELIMINARY PROSPECTUS $260,000,000 Colombier Acquisition Corp. III 26,
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordinary sh
• $11.50 — ne Class A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $1,000,000 — s, subject to a limit of the greater of $1,000,000 and 10% of the interest earned on the t
• $100,000 — n (less permitted withdrawals and up to $100,000 of interest income to pay dissolution e
• $1,500,000 — nit, for an aggregate purchase price of $1,500,000 in a private placement that will close
• $0.003 — B ordinary shares at a nominal price of $0.003 per share, our public shareholders will
• $300,000 — ring or thereafter, we will repay up to $300,000 in loans made to us by our sponsor to c
• $10,000 — e of our sponsor, in an amount equal to $10,000 per month for administrative and shared
• $0.12 — _________ (1) Represents approximately $0.12 per unit, equal to approximately 1.2% o
• $3,000,000 — the gross proceeds of this offering, or $3,000,000 in the aggregate that is payable in cas
• $260 m — ent units described in this prospectus, $260 million, or $299 million if the underwrit
• $299 million — ed in this prospectus, $260 million, or $299 million if the underwriters' overallotment opti

Filing Documents

• ea0261111-01.htm (S-1) — 4210KB
• ea026111101ex4-4_colombier3.htm (EX-4.4) — 222KB
• ea026111101ex10-1_colombier3.htm (EX-10.1) — 22KB
• ea026111101ex10-5_colombier3.htm (EX-10.5) — 52KB
• ea026111101ex23-1_colombier3.htm (EX-23.1) — 2KB
• ea026111101ex99-3_colombier3.htm (EX-99.3) — 3KB
• ea026111101ex99-4_colombier3.htm (EX-99.4) — 3KB
• ea026111101ex99-5_colombier3.htm (EX-99.5) — 3KB
• ea026111101ex99-6_colombier3.htm (EX-99.6) — 3KB
• ea026111101ex99-7_colombier3.htm (EX-99.7) — 3KB
• ea026111101ex99-8_colombier3.htm (EX-99.8) — 3KB
• ea026111101ex-fee_colombier3.htm (EX-FILING FEES) — 22KB
• 0001213900-25-099955.txt ( ) — 8215KB
• clbr-20251017.xsd (EX-101.SCH) — 8KB
• clbr-20251017_def.xml (EX-101.DEF) — 10KB
• clbr-20251017_lab.xml (EX-101.LAB) — 111KB
• clbr-20251017_pre.xml (EX-101.PRE) — 69KB
• ea0261111-01_htm.xml (XML) — 1253KB
• ea026111101ex-fee_colombier3_htm.xml (XML) — 10KB

Risk Factors

Risk Factors 45 Cautionary Note Regarding Forward-Looking Statements 90

Use of Proceeds

Use of Proceeds 91 Dividend Policy 95

Dilution

Dilution 96 Capitalization 98 Management

View Full Filing

View this S-1 filing on SEC EDGAR